Home

Welcome to the Sarcoma Patient Advocacy Global Network!

Sarcoma Patient Advocacy Global Network (SPAGN) is the global network of national Sarcoma Patient Advocacy Organizations. Today, more than 80 member groups from 5 continents gather under the umbrella of SPAGN, providing a common, international and influential patient voice for sarcoma patients around the globe. SPAGN is working to improve the treatment and care of sarcoma patients through information and support, and by increasing the visibility of sarcoma with policymakers and the public.

SPAGN_Logo_2022_RZ_144

News

SPAGN Annual Conference 2026 Highlights ✨

Photos: Uli Deck A Global Community United by Hope and Collaboration  The SPAGN Annual Conference 2026, held in Stockholm, Sweden at Karolinska University Hospital and Elite Hotel Carolina Tower, once again demonstrated the strength, warmth, and determination of the global sarcoma community. Bringing together patients, advocates, healthcare professionals, researchers, and industry partners from around the…
Read More →

Share Your Experience: Contribute to the CURE ID Sarcoma

Patients, care partners, and healthcare providers are invited to share their experiences through the Sarcoma Treatment Survey on CURE ID. CURE ID is a free website and mobile app developed by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) in collaboration with several patient and clinical organizations. The platform…
Read More →

WECAN Patient Experience Data (PED) online course launching on World Cancer Day 

Are you part of a patient organisation that wants to shape healthcare decisions, but doesn’t always know where to start? On 4 February, WECAN Foundation will launch a free online course on Patient Experience Data (PED) for patients, advocates, patient leaders but also people interested in generating PED within the cancer advocacy work. This launch comes at a time when patient experience and quality of life are receiving…
Read More →

🧪 New study arm in rEECur trial with Trabectedin for relapsed Ewing sarcoma

Birmingham/Manchester, UK, January 21, 2026 Ewing sarcoma, a rare bone and soft tissue cancer in children and young adults has poor outcomes at relapse. The drug trabectedin offers a hopeful new option for treatment. Patient advocates have collaborated with investigators and the manufacturer of trabectedin, to open a new treatment arm containing trabectedin within rEECur,…
Read More →

CTOS 2025 Highlights✨

Connective Tissue Oncology Society (CTOS) 2025 Annual Meeting November 12-15, 2025 – Boca Raton, Florida After four intensive days, this year’s CTOS Annual Meeting has ended. Once again, it proved to be the central gathering place for the international sarcoma community -bringing together physicians, healthcare professionals, researchers, industry partners, and patient advocates to discuss new…
Read More →

Statement on Discontinued Development of Brigimadlin

In light of the recent online discussions about brigimadlin, we would like to briefly recap the key information we shared a few weeks ago regarding SPAGN’s engagement in exploring the potential continuation of the drug’s development. We hope this summary helps you provide accurate information should any questions arise within your organizations or institutions. Here…
Read More →

The SPAGN Blog

One goal, many solutions: A patient’s view on ISOLS

Participating at an international congress on limb-saving surgery was overwhelming yet eye-opening for Stéphanie Anzellotti. She is a patient advocate at Cum Cura in Belgium and mother of a child who suffers from osteosarcoma. Stéphanie shares what she is taking home as her key learnings from this experts’ meeting.
Read More →

ROGER EXPLORES… the evolution of clinical trials

Exciting progress is made in the field of clinical trials, finds Roger Wilson. He has participated in several exercises of clinical trial design as a patient advocate. Roger explains the what's what of the latest developments.
Read More →

Patient pathways must improve in Bulgaria – First national campaign on sarcoma shows how

The bitter experience of not finding the information they needed when their son was diagnosed with osteosarcoma, made Lidiya Vitanova and her husband give a promise: No family in Bulgaria should navigate sarcoma alone. They founded Together Fighting Sarcoma and pulled off a national campaign which won the third place of SPAGN’s Advocacy in Action Awards.
Read More →

Every patient matters: Building the future of synovial sarcoma research

This year’s winner of the first prize of SPAGN’s Advocacy in Action Awards is the Synovial Sarcoma Foundation based in the US. With a mission to advance research into this rare and aggressive cancer, they established a biorepository and registry to gather patient data. Synovial sarcoma patients worldwide can participate in this game-changing program. Julie Kramer, a synovial sarcoma survivor herself, gives us the background.
Read More →

From listening to action: Patients’ voices are shaping sarcoma care in Italy

Concrete improvements in sarcoma care in Italy are becoming a reality. The country’s first Sarcoma White Paper maps out 14 recommendations based on patients’ priorities, and its implementation has already begun. The Fondazione Paola Gonzato-Rete Sarcoma ETS, founded by Ornella Gonzato, was honored for this landmark initiative last May by SPAGN with an Advocacy in Action Award. Martina Gherlinzoni, a member of the Foundation’s Board of Directors, explains what makes their project so distinctive that it has become a major national news story in Italy.
Read More →

By bike from Berlin to the Taj Mahal: Young Ewing sarcoma survivor starts charity tour

At the age of 22, John Müller was diagnosed with an Ewing sarcoma, followed by ten months of multimodal therapy. Three years later, he plans to set off by bicycle from Germany to India. His goal: to raise awareness of Ewing sarcomas and to mobilize donations for an emergency fund for sarcoma patients, particularly adolescents and young adults (AYA). Shortly before the start of his journey, John spoke with Voices of Sarcoma.
Read More →

Working together, making a difference.

SPAGN and Members

The network only is as strong as its members. SPAGN welcomes every sarcoma, GIST or desmoid patient group and individuals interested in sarcomas worldwide to become part of our network and thus strengthen it.

Events and Projects

SPAGN not only hosts a variety of events, but also participates in congresses and external events. It is our aim to represent the patients' voice wherever suitable, necessary and potentially helpful to achieve our goals, foremost to improve the situation of sarcoma patients around the globe. Find out more in our section "Events & Projects"

Experts & Research

Sarcomas are rare. It is therefore very important to find physicians or even better multidisciplinary teams who have experience with this disease. SPAGN is setting up alist of sarcoma centers or centers with sarcoma expertise per country. Find out more here.

Sarcoma Facts & Figures

Sarcomas are a diverse and relatively rare group of malignant tumors. The vast majority of diagnosed sarcomas are soft tissue sarcomas, while malignant bone tumors make up just over 10%.

Find out more about Soft Tissue Sarcomas, Bone Sarcomas, GIST and Desmoid Tumors in our section "Sarcoma Facts & Figures"

Blog, News and Newsletter

Please visit our News section or our SPAGN Blog "Voices of Sarcoma". To get regular information, please sign up for our Newsletter today!